Literature DB >> 8692272

Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome.

R Rousset1, C Desbois, F Bantignies, P Jalinot.   

Abstract

The viral Tax protein, which is encoded by human T-cell leukaemia virus HTLV-I, activates nuclear translocation of the NF-kappa B/Rel transcription factors and relieves cytoplasmic sequestration of RelA and Rel by heterodimerization with NF-kappa B1/p1O5 (refs 1,2). Proteolytic maturation of this precursor protein is performed by the proteasome complex. Here we show that Tax binds specifically to two subunits of the 20S proteasome, HsN3 and HC9. This interaction is weakened with HsN3 and lost for HC9 when a mutant of Tax is substituted that is selectively defective for NF-kappa B activation. Immunoprecipitation shows that p1O5 binds weakly to HC9 and that this interaction is reinforced by Tax. No bridging function of Tax between p1O5 and HsN3 was observed. From these results, we propose that Tax accelerates the proteolytic maturation of P105 by favouring its anchorage to the proteasome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692272     DOI: 10.1038/381328a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  50 in total

Review 1.  Relationships between proteasomes and viral gene products.

Authors:  A S Jarrousse; K Gautier; S Apcher; S Badaoui; G Boissonnet; M H Dadet; L Henry; J P Bureau; H P Schmid; F Petit
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.

Authors:  J Hemelaar; F Bex; B Booth; V Cerundolo; A McMichael; S Daenke
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.

Authors:  R Touitou; J Richardson; S Bose; M Nakanishi; J Rivett; M J Allday
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

4.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.

Authors:  Y Gao; S Lecker; M J Post; A J Hietaranta; J Li; R Volk; M Li; K Sato; A K Saluja; M L Steer; A L Goldberg; M Simons
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  The 26S-proteasome: regulation and substrate recognition.

Authors:  S Dawson; R Hastings; K Takayanagi; S Reynolds; P Løw; M Billett; R J Mayer
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

6.  Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasome.

Authors:  Marlies Löscher; Klaus Fortschegger; Gustav Ritter; Martina Wostry; Regina Voglauer; Johannes A Schmid; Steven Watters; A Jennifer Rivett; Paul Ajuh; Angus I Lamond; Hermann Katinger; Johannes Grillari
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

7.  The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.

Authors:  Timothy R Geiger; Neelam Sharma; Young-Mi Kim; Jennifer K Nyborg
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

Review 8.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

9.  Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein.

Authors:  Sébastien Landry; Marilène Halin; Amandine Vargas; Isabelle Lemasson; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter.

Authors:  Young-Mi Kim; Neelam Sharma; Jennifer K Nyborg
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.